Experimental and Theoretical Data on Excitable Artificial Lipidic Membranes

por Monnier, A. M.
Publicado 1968

Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure

por Bonneterre, J, Roché, H, Monnier, A, Guastalla, J P, Namer, M, Fargeot, P, Assadourian, S
Publicado 2002

Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers?

por Pean De Ponfilly, G., Pilmis, B., El Kaibi, I., Castreau, N., Laplanche, S., Le Monnier, A.
Publicado 2021

Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study

por Douillard, J Y, Lerouge, D, Monnier, A, Bennouna, J, Haller, A M, Sun, X S, Assouline, D, Grau, B, Rivière, A
Publicado 2001

Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer

por Lortholary, A, Delozier, T, Monnier, A, Bourgeois, H, Bougnoux, P, Tubiana-Mathieu, N, Riffaud, J Ch, Besson, D, Lotz, V, Gamelin, E
Publicado 2003

The Application of the Concept of Resilience in Aging Research and Older Adult Care: A Focus Group Study

por Angevaare, Milou J., Monnier, A. A., Joling, K. J., Smalbrugge, M., Schellevis, F. G., Hertogh, C. M. P. M., Huisman, M.
Publicado 2020

Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.

por Pujol, J. L., Monnier, A., Berille, J., Cerrina, M. L., Douillard, J. Y., Rivière, A., Grandgirard, A., Gouva, S., Bizzari, J. P., Le Chevalier, T.
Publicado 1994

Dynamique de l’excrétion virale chez les patients infectés par le SARS-CoV-2

por Toulemonde, P.E., Vidal, B., Mizrahi, A., Nguyen Van, J.C., Lourtet, J., El Helali, N., Perniceni, L., Le Monnier, A., Couzigou, C.
Publicado 2020

Evolution of anti-SARS-CoV-2 immune response in a cohort of French healthcare workers followed for 7 months

por Pilmis, B., Elkaibi, I., Péan de Ponfilly, G., Daikha, H., Bouzid, A., Guihot, A., Castreau, N., Pradere, P., Ketatni, H., Mondragon, A., Hayem, G., Le Pavec, J., Laplanche, S., Le Monnier, A.
Publicado 2022

Prevalence and pathogenicity of binary toxin–positive Clostridium difficile strains that do not produce toxins A and B

por Eckert, C., Emirian, A., Le Monnier, A., Cathala, L., De Montclos, H., Goret, J., Berger, P., Petit, A., De Chevigny, A., Jean-Pierre, H., Nebbad, B., Camiade, S., Meckenstock, R., Lalande, V., Marchandin, H., Barbut, F.
Publicado 2014

Epirubicin–vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial

por Kerbrat, P, Roché, H, Bonneterre, J, Veyret, C, Lortholary, A, Monnier, A, Fumoleau, P, Fargeot, P, Namer, M, Chollet, P, Goudier, M-J, Audhuy, B, Simon, H, Montcuquet, P, Eymard, J-C, Walter, S, Clavère, P, Guastalla, J-P
Publicado 2007